The South San Francisco, Calif., biopharmaceutical company in May shut down two trials of zelnecirnon, which was being evaluated as a treatment for asthma and atopic dermatitis.
The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...
Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...
ViewusGlobal on MSN2d
Itchy in the Fall? Here’s Why—and What You Can Do to Fix ItAs seasons change, increased itching can occur; hydrate, moisturize, and choose soft fabrics to alleviate discomfort ...
Our atopic dermatitis launch has been steadily gaining since the ... The common clinical attributes of ZORYVE across ...
Zenrelia is a once-daily oral tablet for canine allergic itch and inflammation. Learn more about this new treatment for dogs.
The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...
The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback